Sienna Biopharmaceuticals

Developer of silver plasmonic therapy for acne and permanent hair removal

placeWestlake Village, California, United States calendar_todayFounded 2016 groups39 employees language siennabio.com

Innovation

16 patent families (3 granted) — focus: Human necessities; filing pace slowing. Cited 8,903 times.

YearFilings
20151
20163
20173
20189
20196
20208
20211
20221
20231

Investor mix

12 investors on record; lead investors include Arch Venture Partners, VenVest Capital; 1 has since exited.

Investor typeCountShare
Venture capital758%
Private equity217%
Bank & private debt217%
Other / undisclosed18%
Coming soon